Myopericarditis in a Young Adult Secondary to COVID-19 Vaccination

Corbin G. Walters, Dev D. Jaiswal, Tom X. Hu, Steve S. Kim

Research output: Contribution to journalArticlepeer-review

Abstract

We present the case of a healthy 29-year-old male with no significant medical history who presented with electrocardiogram findings consistent with pericarditis and elevated troponin levels, commonly seen in myocarditis, after receiving his second Pfizer-BioNTec vaccination for SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2). The patient had significant clinical improvement shortly after receiving aspirin and colchicine and was discharged home with these medications. His laboratory findings returned to baseline less than 2 weeks after his illness. While this case highlights the importance of diagnosis, intervention selection, and treatment of myopericarditis amid ongoing global vaccination campaigns, it should be emphasized that the benefits of vaccination considerably outweigh the risks.

Original languageEnglish
Pages (from-to)13-17
Number of pages5
JournalMethodist DeBakey cardiovascular journal
Volume17
Issue number3
DOIs
StatePublished - 2021

Keywords

  • COVID-19
  • SARS-CoV-2
  • echocardiography
  • myocarditis
  • pericarditis
  • vaccination

Fingerprint

Dive into the research topics of 'Myopericarditis in a Young Adult Secondary to COVID-19 Vaccination'. Together they form a unique fingerprint.

Cite this